In the News
ACP's annual report for 2023-2024 released
Read the new comprehensive report from ACP's CEO and Executive Vice President to learn how ACP is working for you and with you.
ACE inhibitors/ARBs reduced kidney failure but not mortality in chronic kidney disease
Initiation of an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor blocker (ARB) reduced risk of progression to kidney failure by 34% among patients with a baseline estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m2, a meta-analysis found.
MKSAP Quiz: Abnormal finding on a chest radiograph
A 31-year-old man is evaluated following an abnormal finding on a chest radiograph obtained as a part of pre-employment screening. He is a lifelong nonsmoker, his medical history is unremarkable, and he has no known respiratory or constitutional symptoms. Following a physical exam and other tests, what is the most appropriate management?
Discontinuing OAC associated with heightened risk of recurrent stroke, study finds
Among patients with atrial fibrillation prescribed oral anticoagulation (OAC) after a stroke, recurrent stroke rates were 13.4% versus 6.8% in those who did and did not discontinue OAC therapy, a Danish study found.
Female residents experience greater EHR burden, inbasket volume than male residents
A comparison of notes and inbaskets of 156 internal medicine residents found that female residents receive 34% more patient advice requests per day worked than their male colleagues and spent significantly more time in their inbaskets per day.
ACP joins other major health organizations supporting Surgeon General advisory on firearm violence
ACP continues advocating for more common-sense policies that will help reduce firearm-related injuries and deaths.
Put words in our mouth
I.M. Matters Weekly from ACP wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.